emtricitabine
UkraineDrugs containing this active substance
-
This drug is a combination therapy for the treatment of HIV infection (human immunodeficiency virus type 1) in adults and adolescents aged 10 years and older weighing at least 35 kg.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR06
Manufacturer: StridePharma Science Limited
-
The drug is prescribed as part of combination therapy for the treatment of HIV-1 infection in adults and adolescents (from 12 years of age weighing at least 35 kg). It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact in adults and adolescents at high risk.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR03
Manufacturer: Hetero Labs Limited
-
The drug is indicated as part of combination therapy for the treatment of HIV-1-infected adults, as well as adolescents aged 12 to 18 years, if there are contraindications to the use of first-line drugs.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR03
-
The drug is intended for the treatment of adults and children (from 12 years of age with a body weight of at least 40 kg) infected with human immunodeficiency virus type 1 (HIV-1), in combination with other antiviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg emtricitabine 200 mg tenofovir alafenamide 25 mg ATC: J05AR
Manufacturer: Maylan Laboratories Limited
-
The drug is used for the treatment of adults and adolescents (from 12 years of age weighing at least 35 kg) infected with HIV-1, in combination with other antiretroviral agents. It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact in men at risk.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 25 mg ATC: J05AR17
Manufacturer: Anorra Pharma Private Limited
-
The drug is used for the treatment of HIV-1 infection in adults and adolescents (from 12 years of age weighing at least 35 kg) as part of combination therapy. It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 sexual transmission in men at risk.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 25 mg ATC: J05AR17
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used in combination therapy for the treatment of adults with HIV-1. It may also be prescribed to adolescents aged 12 to 18 years if existing treatment methods are unsuitable due to viral resistance or side effects.
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg ATC: J05AR03
Manufacturer: Emcure Pharmaceuticals Ltd
-
The drug is used in combination therapy for the treatment of adults with HIV-1 infection.
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg ATC: J05AR03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of HIV infection (human immunodeficiency virus type 1) in adults aged 18 years and older who are already receiving antiretroviral therapy and have a blood virus level of less than 50 copies/ml.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR06
Manufacturer: Hetero Labs Limited